Sabine Heijhuurs
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Cis- and trans-binding chimeric costimulatory receptors enhance T-cell fitness and tumor control.
Journal: Cellular & molecular immunology
Published: July 15, 2025
Mapping T cell dynamics to molecular profiles through behavior-guided transcriptomics.
Journal: Nature protocols
Published: April 26, 2024
Engineering anti-BCMA CAR T cells for enhancing myeloma killing efficacy via apoptosis regulation.
Journal: Nature communications
Published: November 21, 2023
Engineering anti-BCMA CAR T cells for enhancing myeloma killing efficacy via apoptosis regulation.
Journal: Nature communications
Published: November 21, 2023
Dual targeting of cancer metabolome and stress antigens affects transcriptomic heterogeneity and efficacy of engineered T cells.
Journal: Nature immunology
Published: December 29, 2022
Gamma delta TCR anti-CD3 bispecific molecules (GABs) as novel immunotherapeutic compounds.
Journal: Journal for immunotherapy of cancer
Published: November 02, 2021
Adding Help to an HLA-A*24:02 Tumor-Reactive γδTCR Increases Tumor Control.
Journal: Frontiers in immunology
Published: August 03, 2021
TEG011 persistence averts extramedullary tumor growth without exerting off-target toxicity against healthy tissues in a humanized HLA-A*24:02 transgenic mice.
Journal: Journal of leukocyte biology
Published: October 28, 2019
Identification of a tumor-specific allo-HLA-restricted γδTCR.
Journal: Blood advances
Published: January 28, 2019
Evaluating in vivo efficacy - toxicity profile of TEG001 in humanized mice xenografts against primary human AML disease and healthy hematopoietic cells.
Journal: Journal for immunotherapy of cancer
Published: August 17, 2018
GMP-Grade Manufacturing of T Cells Engineered to Express a Defined γδTCR.
Journal: Frontiers in immunology
Published: February 07, 2018
Last Updated: 09/26/2026